When a drug called Remdesivir showed promising signs in preliminary COVID-19 trials, the US allowed it to be used in hospitals. But around the globe, access to this new drug has been extremely difficult. In fact, it’s unclear whether huge parts of Latin America, especially, hit hard by COVID-19, will have a way to get it at all. The World’s Elana Gordon reports.
We want to hear your feedback so we can keep improving our website, theworld.org. Please fill out this quick survey and let us know your thoughts (your answers will be anonymous). Thanks for your time!